[Elsevier] Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

Huaks Post time 2024-5-7 14:04:52 | Show all posts |Read mode
Reward10points


Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
NORANISAH Post time 2024-5-7 14:04:53 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    40

Latest Reply

Return to the list